Normal Lab Values

Front 1

ACT

Back 1

150-180

Front 2

Anion Gap

Back 2

8-16 mEq/L

Front 3

Albumin

Back 3

3.8-4.5 g/dL

Front 4

ALT, SGPT

Back 4

1-45 U/L

Front 5

Bilirubin (Indirect)

Back 5

0.1-1 mg/dL

Front 6

Bilirubin (Direct)

Back 6

0.1-0.3 mg/dL

Front 7

Bilirubin (Total)

Back 7

0.2-1.3 mg/dL

Front 8

BUD

Back 8

10-25 mg/dL

Front 9

Ca+ (ionized)

Back 9

4.5-5.5 mEq/L

Front 10

Ca+ (total)

Back 10

9-11 mEq/L

Front 11

Capillary refill

Back 11

< 2-3 sec

Front 12

Cl-

Back 12

96-106 mEq/L

Front 13

Creatinine

Back 13

0.6-1.2 mg/dL

Front 14

Glucose

Back 14

70-120 mg/dL

Front 15

GGT

Back 15

5-4OU/L

Front 16

Iron (total-binding)

Back 16

45-73 μmol/L

Front 17

Iron (serum)

Back 17

9-26.9 μmol/L

Front 18

K+

Back 18

3.5-5.5 mEq/L

Front 19

Lactic Acid

Back 19

0.6-2.2 mEq/L

Front 20

Mg+

Back 20

1.5-2.5 mEq/L

Front 21

Na+

Back 21

135-145 mEq/L

Front 22

Osmolarity of serum

Back 22

275-295 mOsm/kg

Front 23

Phosphate

Back 23

2.8-4.5 mEq/L

Front 24

Protamine Sulfate

Back 24

Negative

Front 25

Transferrin

Back 25

250-430 mg/dL

Front 26

Hemoglobin (Hgb)

Determines the amount of hemoglobin/100 mL of blood. The test is used to: measure the severity of anemia or polycythemia, monitor the response to treatment of anemia or polycythemia, and help make decisions about blood transfusions if the anemia is severe.

Back 26

Man: 13 - 18 g/dL
Woman: 12 - 16 g/dL
Child (3-12 yr): 11 - 12.5 gm/dL

Hint 26

Above-normal hemoglobin levels may be the result of: dehydration, excess production of red blood cells in the bone marrow, severe lung disease, or several other conditions.

Below-normal hemoglobin levels may lead to anemia that can be the result of: iron deficiency or other deficiencies, such as B12 and folate, inherited hemoglobin defects, such as sickle cell anemia or thalassemias, other inherited conditions, such as enzyme defects, cirrhosis of the liver, excessive bleeding,
excessive destruction of red blood cells, kidney disease, other chronic illnesses, bone marrow failure or aplastic anemia, or
cancers that affect the bone marrow.

Front 27

Hematocrit

Measures percentage of red blood cells per fluid volume of blood. This test is used to evaluate: anemia, polycythemia, response to treatment of anemia or polycythemias, dehydration, blood transfusion decisions for severe symptomatic anemias, and the effectiveness of those transfusions.

Back 27

Man: 42 - 50%
Woman: 40 - 48%
Child (3-12 yrs): 35 - 45%

Hint 27

Decreased hematocrit: anemia, such as that caused by iron deficiency or other deficiencies. Other conditions that can result in a low hematocrit include vitamin or mineral deficiencies, recent bleeding, cirrhosis of the liver, and malignancies.

Increased hematocrit: dehydration, polycythemia vera—that

Front 28

Red blood cell count (RBC), erythrocytes

Determines actual number of RBC in relation to volume

Back 28

Man: 4.6 - 6.2 million/mm⁵
Woman: 4.2 - 5.4 million/mm⁵
Child: 3.2 - 5.2 million/mm⁵

Hint 28

Decreased RBC: Trauma, Burns, Pregnancy, Hemolytic anemia, Hemorrhagic infections, Gastrointestinal (GI) or other vascular bleed, Iron deficiency anemia, Vitamin B12 or folate deficiency, bone marrow damage, Metabolic disorders, Chronic inflammation

Increased RBC: Dehydration, Pulmonary disease, Congenital heart disease, Polycythemia vera, Renal problems, Over-transfusion of whole blood, Tissue hypoxia

Front 29

Reticulocyte count

Back 29

0.5-1.5% of RBC count

Front 30

MCHC

Back 30

32-36%

Front 31

mch

Back 31

27-33 pg

Front 32

MCV

Back 32

82-98 fl

Front 33

White blood cell count (WBC), leukocytes

Back 33

Adult: 5,000 - 10,000/mm

Hint 33

Establishes amount and maturity of white blood cell elements

Front 34

Bands

Back 34

3-5%

Front 35

Basophils

Back 35

0-2%

Front 36

Eosinophils

Back 36

2-4%

Front 37

Lymphocytes

Back 37

20-40%

Front 38

Monocytes

Back 38

4-8%

Front 39

Neutrophils

Back 39

50-70%

Front 40

Partial Thromboplastin Time (PTT) or Activated Partial Thromboplastin Time (aPTT)

Monitors effectiveness of heparin therapy, detects coagulation disorders.

Back 40

20-39 seconds

Hint 40

A decreased PTT may result when coagulation factor VIII is elevated. This may occur during an acute phase reaction, a condition causing acute tissue inflammation or trauma. This is usually a temporary change that is not monitored with the PTT. When the condition causing the acute phase reaction is resolved, the PTT will return to normal.

A prolonged PTT means that clotting is taking longer to occur than expected and may be caused by a variety of factors (see the list below). Often, this suggests that there may be a coagulation factor deficiency or a specific or nonspecific inhibitor affecting the body’s clotting ability. Coagulation factor deficiencies may be acquired or inherited. Several factors are Vitamin K dependent. If a person has liver disease, for instance, or more rarely a Vitamin K deficiency, he may have one or more factor deficiencies. Inherited factor deficiencies may affect the quantity and/or function of the factor produced.

Inhibitors may be antibodies that specifically target certain coagulation factors, such as Factor VIII antibodies, or they may be non-specific inhibitors, such as lupus antocoagulant and anticardiolipin antibodies that bind to chemicals called phospholipids found on the surface of platelets. Since phospholipids assist in the clotting process, and since the PTT test reagents (chemicals used to run the tests) contain phospholipids, such antibodies may prolong the PTT even though they are usually associated with thrombosis instead of bleeding.

Front 41

PT

Back 41

12-15 sec

Front 42

Platelet

Back 42

150-400 X 10^9

Front 43

Fibrin Split Products

Back 43

< 10 mg/L

Front 44

d-dimer

Back 44

150-400 mg/dL

Front 45

INR

Back 45

<2

Front 46

Bleeding Time

Measures duration of bleeding after standardized skin incision. Used for preoperative screening.

Back 46

1 - 9 min

Front 47

ESR

Back 47

1-20 mm in 1 hr

Front 48

Fibrinogen

Back 48

200-400 mg/dL

Front 49

Thrombin Time

Back 49

8-12 sec

Front 50

BP

Back 50

120/80 (>90/50)

Front 51

BEAT

Back 51

(HR) 60-100

Front 52

Cl

Back 52

2.5-4 L/MIN/M2

Front 53

CO

Back 53

4-8 LPM

Front 54

CVP

Back 54

2-6 mmHg

Front 55

CPP

Back 55

70-90 mmHg

Front 56

EF

Back 56

>75%

Front 57

ICP

Back 57

0-15 (@ 20-25 TX)

Front 58

PA SBP

Back 58

15-25 mmHg

Front 59

PA DBP

Back 59

8-12 mmHg

Front 60

PAOP

Back 60

8-12 mmHg

Front 61

MAP

Back 61

80-100 mmHg

Front 62

SV

Back 62

60-100 ML/BEAT

Front 63

SVR

Back 63

800-1200 D+S/CM5/M2

Front 64

ETCO2

Back 64

35-45 mmHg

Front 65

RR

Back 65

10-22 bpm

Front 66

TV

Back 66

5-7 ml/Kg

Front 67

Volume of dead space

Back 67

150 ml (2 ml/kg)

Front 68

Volume capacity

Back 68

40-70 ml/kg

Front 69

V/Q ratio

Back 69

0.8

Front 70

pH

Back 70

7.35-7.45

Front 71

PCO2

Back 71

35-45 mmHg

Front 72

HCO-

Back 72

20-30 mEq/L

Front 73

Base Excess

Back 73

+/- 2.0 mEq/L

Front 74

PO2

Back 74

80-100 mmHg

Front 75

O2 Saturation

Back 75

96-100%

Front 76

Urine Sp Gr

Back 76

1.001-1.030

Front 77

Urine pH

Back 77

4.6-8.0